WuXi Biologics (Cayman) Inc. (WXIBF) revealed earnings for its first half that Increases, from last year
The company's earnings came in at RMB2.339 billion, or RMB0.55 per share. This compares with RMB1.499 billion, or RMB0.35 per share, last year.
Excluding items, WuXi Biologics (Cayman) Inc. reported adjusted earnings of RMB2.840 billion or RMB0.56 per share for the period.
The company's revenue for the period rose 16.1% to RMB9.953 billion from RMB8.574 billion last year.
WuXi Biologics (Cayman) Inc. earnings at a glance (GAAP) :
-Earnings: RMB2.339 Bln. vs. RMB1.499 Bln. last year.-EPS: RMB0.55 vs. RMB0.35 last year.-Revenue: RMB9.953 Bln vs. RMB8.574 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.